Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review (Q35121392)

6 August 2017

0 references

1 reference

title

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review (English)

1 reference

chronic obstructive pulmonary disease

6 August 2017

0 references

1 reference

1 reference

Olivier Bruyere

10

0 references

Jean-Yves Reginster

11

object named as

Jean-Yves Reginster

1 reference

6 August 2017

1

Florent Richy

1 reference

6 August 2017

Jean-Pierre Devogelaer

7

object named as

Jean-Pierre Devogelaer

1 reference

6 August 2017

2

Jean Bousquet

1 reference

6 August 2017

George E Ehrlich

3

1 reference

6 August 2017

Pierre J Meunier

4

1 reference

6 August 2017

Elliot Israel

5

1 reference

6 August 2017

Hirotoshi Morii

6

1 reference

6 August 2017

Nicola Peel

8

1 reference

6 August 2017

Muriel Haim

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

23 April 2003

1 reference

Osteoporosis International

6 August 2017

1 reference

6 August 2017

14

1 reference

6 August 2017

179-190

1 reference

6 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-003-1398-z

6 August 2017

0 references

cites work

Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group

1 reference

12 December 2020

Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate

1 reference

12 December 2020

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

1 reference

12 December 2020

Bone mineral density in prepubertal asthmatics receiving corticosteroid treatment

1 reference

12 December 2020

Identifying relevant studies for systematic reviews

1 reference

12 December 2020

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

12 December 2020

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

1 reference

12 December 2020

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

1 reference

12 December 2020

1 reference

12 December 2020

Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial

1 reference

12 December 2020

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

12 December 2020

Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease

1 reference

12 December 2020

Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.

1 reference

12 December 2020

A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.

1 reference

12 December 2020

Corticosteroids and fractures: a close encounter of the third cell kind.

1 reference

12 December 2020

Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women

1 reference

12 December 2020

The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide

1 reference

12 December 2020

Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women

1 reference

12 December 2020

Risk of osteoporosis in men with chronic bronchitis

1 reference

12 December 2020

Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease

1 reference

12 December 2020

Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.

1 reference

12 December 2020

Morbidity from asthma in relation to regular treatment: a community based study

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin

1 reference

12 December 2020

Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test

1 reference

12 December 2020

Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids

1 reference

12 December 2020

Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma

1 reference

12 December 2020

Vertebral fractures resulting from prolonged cortisone and corticotropin therapy

1 reference

12 December 2020

Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism

1 reference

12 December 2020

Use of inhaled corticosteroids and risk of fractures.

1 reference

12 December 2020

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

12 December 2020

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

12 December 2020

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

12 December 2020

Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis

1 reference

12 December 2020

Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease

1 reference

12 December 2020

10.1007/S00198-003-1398-Z

Identifiers

DOI

1 reference

6 August 2017

1 reference